EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Bioengineered in vitro three-dimensional tumor models in endocrine cancers

Aleksander Skardal iD, Hemamylammal Sivakumar, Marco A Rodriguez, Liudmila V Popova, Priya H Dedhia

Endocrine-Related Cancer · 02.02.2024 · 31 (4)

DOI: 10.1530/erc-23-0344 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Endocrine-Related Cancer, erschienen am 02.02.2024. Verfasst von Aleksander Skardal und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, The Ohio State University, Columbus, Ohio, USA. Hauptthemen laut MEDLINE: Endocrine Gland Neoplasms, Thyroid Neoplasms, Neuroendocrine Tumors, Adrenal Cortex Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Graphical abstract Abstract Endocrine tumors are a heterogeneous cluster of malignancies that originate from cells that can secrete hormones. Examples include, but are not limited to, thyroid cancer, adrenocortical carcinoma, and neuroendocrine tumors. Many endocrine tumors are relatively slow to proliferate, and as such, they often do not respond well to common antiproliferative chemotherapies. Therefore, increasing attention has been given to targeted therapies and immunotherapies in these diseases. However, in contrast to other cancers, many endocrine tumors are relatively rare, and as a result, less is understood about their biology, including specific targets for intervention. Our limited understanding of such tumors is in part due to a limitation in model systems that accurately recapitulate and enable mechanistic exploration of these tumors. While mouse models and 2D cell cultures exist for some endocrine tumors, these models often may not accurately model nuances of human endocrine tumors. Mice differ from human endocrine physiology and 2D cell cultures fail to recapitulate the heterogeneity and 3D architectures of in vivo tumors. To complement these traditional cancer models, bioengineered 3D tumor models, such as organoids and tumor-on-a-chip systems, have advanced rapidly in the past decade. However, these technologies have only recently been applied to most endocrine tumors. In this review we provide descriptions of these platforms, focusing on thyroid, adrenal, and neuroendocrine tumors and how they have been and are being applied in the context of endocrine tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endocrine Gland NeoplasmsThyroid NeoplasmsNeuroendocrine TumorsAdrenal Cortex NeoplasmsHumansMiceAnimalsOrganoids

Stichwörter der Autor:innen

bioengineeredin vitromodelsorganoidsthree-dimensional

Autor:innen und Institutionen

  • Department of Biomedical Engineering, The Ohio State University, Columbus, Ohio, USA.
  • The Ohio State University and Arthur G. James Comprehensive Cancer Center, Columbus, Ohio, USA.
  • Center for Cancer Engineering, The Ohio State University, Columbus, Ohio, USA.
  • Division of Surgical Oncology, The Ohio State University and Arthur G. James Comprehensive Cancer Center, Columbus, Ohio, USA.

ORCID-Profile: Aleksander Skardal

Förderung

  • NCI NIH HHS

Zitieren

APA

Skardal, A., Sivakumar, H., Rodriguez, M. A., Popova, L. V., & Dedhia, P. H. (2024). Bioengineered in vitro three-dimensional tumor models in endocrine cancers. Endocrine-Related Cancer, 31(4). https://doi.org/10.1530/erc-23-0344

Vancouver

Skardal A, Sivakumar H, Rodriguez MA, Popova LV, Dedhia PH. Bioengineered in vitro three-dimensional tumor models in endocrine cancers. Endocrine-Related Cancer. 2024;31(4). doi:10.1530/erc-23-0344

BibTeX
@article{Skardal2024,
  author = {Skardal, Aleksander and Sivakumar, Hemamylammal and Rodriguez, Marco A and Popova, Liudmila V and Dedhia, Priya H},
  title = {Bioengineered in vitro three-dimensional tumor models in endocrine cancers},
  journal = {Endocrine-Related Cancer},
  year = {2024},
  volume = {31},
  number = {4},
  doi = {10.1530/erc-23-0344}
}
Kostenlos starten →